Controlling Rotavirus-associated diarrhea: Could single-domain antibody fragments make the difference? = Hacia el control de la diarrea por rotavirus A: ¿podrían los nanoanticuerpos VHH marcar la diferencia?
Group A Rotavirus (RVA) remains a leading cause of severe diarrhea and child mortality. The variable domain of camelid heavy chain antibodies (VHH) display potent antigen-binding capacity, have low production costs and are suitable for oral therapies. Two sets of anti-RVA VHHs have been developed: A...
| Autores principales: | , , , |
|---|---|
| Formato: | info:ar-repo/semantics/artículo |
| Lenguaje: | Inglés |
| Publicado: |
Asociación Argentina de Microbiología
2018
|
| Materias: | |
| Acceso en línea: | http://hdl.handle.net/20.500.12123/3581 https://www.sciencedirect.com/science/article/pii/S0325754115001261?via%3Dihub#! https://doi.org/10.1016/j.ram.2015.09.005 |
Ejemplares similares: Controlling Rotavirus-associated diarrhea: Could single-domain antibody fragments make the difference? = Hacia el control de la diarrea por rotavirus A: ¿podrían los nanoanticuerpos VHH marcar la diferencia?
- Llamas : diagnóstico eficaz del Rotavirus
- Prevención y tratamiento de Rotavirus A mediante nanoanticuerpos VHH anti-VP6
- A new passive immune strategy based on IgY antibodies as a key element to control neonatal calf diarrhea in dairy farms
- Anti-VP6 VHH : an experimental treatment for rotavirus A-associated disease
- Molecular and antigenic characterization of bovine Coronavirus circulating in Argentinean cattle during 1994–2010
- Prevalence, risk factors and molecular epidemiology of neonatal cryptosporidiosis of calves : The Argentine perspective